Transitioning From Pediatric to Adult Cystic Fibrosis Care: Role of Shared Decision-Making
CE Information
0.25 CE creditsCompletion Time
15 minutesAvailable Until
June 6, 2024Posted By
Prime CE
Navigate
Overview
Specialties
Acute Care, Adult, and PediatricSubspecialties
Endocrinology, Gastroenterology, and Respiratory/PulmonologyClinical Topics
Pediatrics and Primary CareIntended Audience: Multidisciplinary teams who care for patients with cystic fibrosis, including pulmonology, gastroenterology, endocrinology, pediatric, and primary care physicians and their teams of NPs, PAs, nurses, and pharmacists
The transition from pediatric to adult care is a crucial milestone for individuals with cystic fibrosis (CF), as well as their caregivers and care teams. Supporting a seamless and gradual transfer of responsibilities to the person with CF is vital for achieving positive health outcomes.
In this video, expert faculty share lessons from the field and explore best practices and multi-disciplinary strategies to facilitate successful transitions, with an emphasis on shared decision-making.
Learning Objectives
- Align clinical practices with current evidence and guidelines for the management of CF
- Apply interprofessional strategies for optimal CF transitions across the care continuum through shared decision‐making
Speakers
Director, Toronto Adult Cystic Fibrosis Centre
Head, Division of Respirology
St Michael's Hospital
Professor of Medicine
University of Toronto
As the Director of the Toronto Adult Cystic Fibrosis (CF) Clinic at St. Michael's Hospital, Dr. Tullis is responsible for the care of 600 adults with CF. Dr. Tullis is a Professor of Medicine at the University of Toronto, the Respirology Division Head at St. Michael's Hospital, and an Associate Scientist in the Li Ka Shing Knowledge Institute. She was the CF Canada Chair in Adult Cystic Fibrosis from 2014-2019. Dr. Tullis has published over 180 manuscripts and has lectured nationally and internationally on issues related to CF in adults. She has had 30 years of experience with CF clinical care. She has trained 25 CF fellows who are now working in CF clinics around the world. In 2012, she was awarded the Queen Elizabeth II Diamond Jubilee Medal to recognise her contributions to the care of people with cystic fibrosis in Canada. In 2017 she received the Dr Douglas Crozier Award from Cystic Fibrosis Canada in recognition of significant contribution and outstanding dedication to the fight against cystic fibrosis and the Prix d’Excellence-Specialist of the Year award from the Royal College of Physicians and Surgeons of Canada. In 2022, she was awarded the Jeffrey C Lozon Physician Leadership Award, at St Michael's Hospital.
Director, Adult Cystic Fibrosis Program
Associate Professor of Medicine
Johns Hopkins University
Baltimore, MD
Dr. Lechtzin is a pulmonary and critical care medicine physician. He directs the Adult CF program and the neuromuscular pulmonary clinic at Johns Hopkins and is an expert in the treatment of cystic fibrosis, pulmonary complications of neuromuscular disease and the care of critically ill patients in the Medical ICU. He has joint appointments in Epidemiology and Neurology. He is the co-director of the Johns Hopkins CF Therapeutics Development Network site.
CE Information
This activity offers 0.25 CE credits to attendees.
Nurse Practitioner Accreditation Statement
PRIME Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This activity is approved for 0.25 contact hour (which includes 0 hour of pharmacology).
Disclosures
*PRIME® has identified, reviewed, and mitigated all relevant financial relationships that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity.
The following individuals have identified relevant financial relationships with ineligible companies to disclose:
-
Elizabeth Tullis, MD, FRCPC (Speaker)
Advisory Board or Panel – Horizon, Vertex Pharmaceuticals IncThe relationships reported above are related to the following therapeutic area: Respiratory
Speakers Bureau or other Promotional Education – Vertex Pharmaceuticals Inc
Other Financial or Material Support (royalties, patents, etc.) – AbbVie, Vertex Pharmaceuticals Inc -
Noah Lechtzin, MD, MHS (Speaker)
Consultant – Cytokinetics, Ionis, Microbion, RevalesioThe relationships reported above are related to the following therapeutic area: Pulmonary
Grants / Research Support – Vertex -
Kristi Kay Orbaugh, RN, MSN, RNP, AOCN (Planner)
Speakers Bureau or other Promotional Education – AstraZeneca, Bristol-Myers Squibb, CTI, DSI, Dova, Eli Lilly and Company, Gilead SciencesThe relationships reported above are related to the following therapeutic area: Oncology
The following individuals have no relevant financial relationships with ineligible companies to disclose:
- Michele B Kaufman, PharmD, BCGP (Reviewer)
- Annette Sophin, MSMM, PA-C (Planner)
All PRIME® staff participating in planning and content development have no relevant financial relationships with ineligible companies to disclose.
Ready to start this activity?
Login required. You will be redirected to an external website to register for and complete this activity.
Log in and start activity